NCT02820896View on ClinicalTrials.gov

A Study of RO7105705 in Healthy Participants and Participants With Mild-to-Moderate Alzheimer's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

June 29, 2016

Primary Completion Date

June 26, 2017

Study Completion Date

June 26, 2017

Conditions
Alzheimer's Disease
Interventions
DRUG

Placebo

Participants will receive single or multiple doses of RO7105705 matching placebo IV.

DRUG

RO7105705

Participants will receive single or multiple doses of RO7105705 IV or SC.

Trial Locations (1)

37920

New Orleans Center for Clinical Research, Knoxville

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY